Interpace Biosciences®, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Long-Term Debt (Details Narrative)

Long-Term Debt (Details Narrative) - USD ($)				1 Months Ended		3 Months Ended		6 Months Ended
Long-Term Debt (Details Narrative) - USD ($)	Apr. 18, 2017	Mar. 22, 2017	Oct. 31, 2014	Apr. 18, 2017	Dec. 31, 2016	Jun. 30, 2017	Jun. 30, 2016	Jun. 30, 2017	Jun. 30, 2016	Mar. 23, 2017
Interest expense, debt						$ 216,000	$ 858,000	$ 469,000	$ 1,062,000
Extinguishment fair value loss						(2,731,000)		(4,278,000)
Debt conversion, converted instrument, amount								8,869,000
Debt conversion, converted instrument, shares issued				3,795,429
Derivative liability						1,493,000		1,493,000
Senior Secured Convertible Note [Member]
Debt conversion, converted instrument, shares issued				3,795,429
Exchanged Convertible Note and the Senior Secured Convertible Note [Member]
Debt instrument, face amount		$ 3,550,000
Embedded derivative, fair value of embedded derivative liability						208,427,000		208,427,000
Derivative, loss on derivative						19,000,000		61,000,000
Derivative liability						0		0
Debt issuance costs								500,000
RedPath Note [Member]
Debt instrument, face amount			$ 1,070,000		9,340,000
Repayment of debt					1,330,000
RedPath Note [Member] \| Senior Secured Convertible Note [Member]
Debt instrument, face amount						5,320,000		5,320,000
RedPath Note [Member] \| Senior Secured Non-Convertible Note [Member]
Debt instrument, face amount	$ 3,550,000	5,320,000		$ 3,550,000		3,550,000		3,550,000
Debt conversion, converted instrument, amount	$ 3,550,000
Debt conversion, converted instrument, shares issued	3,795,429
RedPath Note [Member] \| Exchanged Convertible Note [Member]
Extinguishment fair value loss								$ 4,300,000
Payment of conversion fees percentage								6.50%
Senior secured debt	$ 2,300,000			$ 2,300,000
RedPath Note [Member] \| Investor [Member]
Debt instrument, face amount		8,870,000
RedPath Note [Member] \| Exchange Agreement [Member]
Debt instrument, face amount					9,340,000
Repayment of debt					1,330,000
RedPath Note [Member] \| Exchange Agreement [Member] \| Exchanged Non-Convertible Note” and “Exchanged Notes [Member]
Debt instrument, face amount										$ 8,870,000
RedPath Note [Member] \| Exchange Agreement [Member] \| Investor [Member]
Business combination cash acquired		$ 8,870,000
RedPath Integrated Pathology, Inc [Member] \| RedPath Note [Member]
Debt instrument, face amount					9,340,000
RedPath Integrated Pathology, Inc [Member] \| Note Payable [Member]
Interest expense, debt						200,000	$ 200,000	$ 200,000	$ 400,000
Debt instrument, unamortized discount					1,400,000
Fair value of debt					9,300,000
Long-term debt					$ 7,900,000
Maxim Group LLC [Member] \| Senior Secured Convertible Note [Member]
Debt instrument, face amount						8,850,000		8,850,000
Cash fees paid						600,000		$ 600,000
Percentage of cash fee paid								6.50%
Senior secured debt						$ 8,850,000		$ 8,850,000
RedPath Acquisition [Member]
Business combination, consideration transferred, liabilities incurred			$ 7,500,000